Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00322842
What this trial is testing

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 35
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Early research (Phase 1)Ended earlyNCT02255162
What this trial is testing

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myelocytic LeukemiaAcute Myelogenous Leukemia+2 more
Massachusetts General Hospital 8
Early research (Phase 1)UnknownNCT03825146
What this trial is testing

The Effects of AMPC in the Treatments of Refractory or Relapsed AML

Who this might be right for
Acute Myeloid Leukaemia Recurrent
Lai Corporation Pty. Ltd. 10
Not applicableStudy completedNCT03210727
What this trial is testing

CAREgiver Study for Patients Undergoing HSCT

Who this might be right for
Neoplasms
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00607854
What this trial is testing

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)

Who this might be right for
Diffuse Large B-Cell LymphomaMantle Cell Lymphoma
University Hospital, Bordeaux 31
Testing effectiveness (Phase 2)Study completedNCT00006890
What this trial is testing

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 67
Testing effectiveness (Phase 2)WithdrawnNCT00002761
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Columbia University
Testing effectiveness (Phase 2)Study completedNCT02221479
What this trial is testing

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 14
Large-scale testing (Phase 3)Study completedNCT01015196
What this trial is testing

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 832
Testing effectiveness (Phase 2)Study completedNCT03019640
What this trial is testing

Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Mantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+4 more
M.D. Anderson Cancer Center 22
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT01440127
What this trial is testing

Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers

Who this might be right for
Colon Cancer
Tufts Medical Center 9
Not applicableEnded earlyNCT00610818
What this trial is testing

Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Skin Rash
McGill University Health Centre/Research Institute of the McGill University Health Centre 7
Not applicableLooking for participantsNCT07579065
What this trial is testing

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Who this might be right for
Hematologic NeoplasmHematopoietic Stem Cell TransplantationSurvivorship+1 more
Azienda USL Reggio Emilia - IRCCS 40
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Next Page